nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert review
|
Ascierto, Paolo A. |
|
2013 |
85 |
2 |
p. 149-161 13 p. |
artikel |
2 |
Anaplastic large cell lymphoma, ALK-negative
|
Ferreri, Andrés J.M. |
|
2013 |
85 |
2 |
p. 206-215 10 p. |
artikel |
3 |
Biliary tract carcinomas: From chemotherapy to targeted therapy
|
Marino, Donatella |
|
2013 |
85 |
2 |
p. 136-148 13 p. |
artikel |
4 |
Editorial Board
|
|
|
2013 |
85 |
2 |
p. CO2- 1 p. |
artikel |
5 |
Features of cancer management in obese patients
|
Hijazi, Hussam |
|
2013 |
85 |
2 |
p. 193-205 13 p. |
artikel |
6 |
Hodgkin lymphoma
|
Gobbi, Paolo G. |
|
2013 |
85 |
2 |
p. 216-237 22 p. |
artikel |
7 |
Issues to be considered when studying cancer in vitro
|
Čunderlíková, Beata |
|
2013 |
85 |
2 |
p. 95-111 17 p. |
artikel |
8 |
Is the combination of Cetuximab with chemo-radiotherapy regimens worthwhile in the treatment of locally advanced head and neck cancer? A review of current evidence
|
Numico, Gianmauro |
|
2013 |
85 |
2 |
p. 112-120 9 p. |
artikel |
9 |
Overview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factors
|
Clarke, Stephen J. |
|
2013 |
85 |
2 |
p. 121-135 15 p. |
artikel |
10 |
The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline
|
Leitch, Heather A. |
|
2013 |
85 |
2 |
p. 162-192 31 p. |
artikel |